178 related articles for article (PubMed ID: 27940597)
41. Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis.
Kuwana M; Feghali CA; Medsger TA; Wright TM
Arthritis Rheum; 2001 Jul; 44(7):1654-9. PubMed ID: 11465716
[TBL] [Abstract][Full Text] [Related]
42. Disease-related autoantibody profile in patients with systemic sclerosis.
Liaskos C; Marou E; Simopoulou T; Barmakoudi M; Efthymiou G; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Autoimmunity; 2017 Nov; 50(7):414-421. PubMed ID: 28749191
[TBL] [Abstract][Full Text] [Related]
43. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
[TBL] [Abstract][Full Text] [Related]
44. Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells.
Kuwana M; Medsger TA; Wright TM
J Immunol; 2000 Jun; 164(12):6138-46. PubMed ID: 10843663
[TBL] [Abstract][Full Text] [Related]
45. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
[TBL] [Abstract][Full Text] [Related]
46. Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis.
Hu PQ; Fertig N; Medsger TA; Wright TM
Arthritis Rheum; 2003 May; 48(5):1363-73. PubMed ID: 12746909
[TBL] [Abstract][Full Text] [Related]
47. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.
Kuwana M; Medsger TA; Wright TM
J Clin Invest; 1995 Jul; 96(1):586-96. PubMed ID: 7615831
[TBL] [Abstract][Full Text] [Related]
48. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain.
Ueki A; Isozaki Y; Tomokuni A; Ueki H; Kusaka M; Tanaka S; Otsuki T; Sakaguchi H; Hyodoh F
Immunobiology; 2001 Dec; 204(4):458-65. PubMed ID: 11776400
[TBL] [Abstract][Full Text] [Related]
49. Heparin inhibits the interaction of DNA topoisomerase I/anti-topoisomerase I immune complexes with heparan sulfate on dermal fibroblasts.
Arcand J; Robitaille G; Koenig M; Senécal JL; Raymond Y
Arthritis Rheum; 2012 May; 64(5):1632-41. PubMed ID: 22095242
[TBL] [Abstract][Full Text] [Related]
50. IL-10-producing regulatory B cells (B10 cells), IL-17+ T cells and autoantibodies in systemic sclerosis.
Mavropoulos A; Liaskos C; Simopoulou T; Bogdanos DP; Sakkas LI
Clin Immunol; 2017 Nov; 184():26-32. PubMed ID: 28502678
[TBL] [Abstract][Full Text] [Related]
51. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.
Villalta D; Morozzi G; Tampoia M; Alpini C; Brusca I; Salgarolo V; Papisch W; Bizzaro N
Clin Chim Acta; 2010 May; 411(9-10):710-3. PubMed ID: 20138166
[TBL] [Abstract][Full Text] [Related]
52. T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I.
Hu PQ; Oppenheim JJ; Medsger TA; Wright TM
J Autoimmun; 2006 Jun; 26(4):258-67. PubMed ID: 16735104
[TBL] [Abstract][Full Text] [Related]
53. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.
Tamby MC; Servettaz A; Guilpain P; Tamas N; Berezné A; Batteux F; Reinbolt J; Guillevin L; Weill B; Mouthon L
Clin Immunol; 2007 Apr; 123(1):82-8. PubMed ID: 17258939
[TBL] [Abstract][Full Text] [Related]
54. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay.
Kuwana M; Kimura K; Kawakami Y
Arthritis Rheum; 2002 Oct; 46(10):2742-7. PubMed ID: 12384934
[TBL] [Abstract][Full Text] [Related]
55. Development of systemic sclerosis in a patient with systemic lupus erythematosus and topoisomerase I antibody.
Katsumi S; Kobayashi N; Yamamoto Y; Miyagawa S; Shirai T
Br J Dermatol; 2000 May; 142(5):1030-3. PubMed ID: 10809868
[TBL] [Abstract][Full Text] [Related]
56. MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I.
Rands AL; Whyte J; Cox B; Hall ND; McHugh NJ
J Autoimmun; 2000 Dec; 15(4):451-8. PubMed ID: 11090244
[TBL] [Abstract][Full Text] [Related]
57. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.
Airo' P; Ceribelli A; Cavazzana I; Taraborelli M; Zingarelli S; Franceschini F
J Rheumatol; 2011 Jul; 38(7):1329-34. PubMed ID: 21459934
[TBL] [Abstract][Full Text] [Related]
58. Identification of a universal B cell epitope on DNA topoisomerase I, an autoantigen associated with scleroderma.
Kato T; Yamamoto K; Takeuchi H; Okubo M; Hara E; Nakada S; Oda K; Ito K; Nishioka K
Arthritis Rheum; 1993 Nov; 36(11):1580-7. PubMed ID: 7694585
[TBL] [Abstract][Full Text] [Related]
59. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.
Gourh P; Tan FK; Assassi S; Ahn CW; McNearney TA; Fischbach M; Arnett FC; Mayes MD
Arthritis Rheum; 2006 Dec; 54(12):3945-53. PubMed ID: 17133608
[TBL] [Abstract][Full Text] [Related]
60. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
